Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses

This publication has 56 references indexed in Scilit:

• Attenuated measles virus as a vaccine vector
  Vaccine, 2007
• Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
  Vaccine, 2006
• Live Attenuated Measles Vaccine as a Potential Multivalent Pediatric Vaccination Vector
  Viral Immunology, 2005
• Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region
  Journal of Virology, 2005
• Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets
  Journal of Virology, 2004
• A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
  International Immunology, 2004
• A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
  Nature, 2004
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
  Science, 2003
• Frequency of Measles Virus-Specific CD4⁺and CD8⁺T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine
  Clinical and Vaccine Immunology, 2003
• Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 Months
  The Journal of Infectious Diseases, 2001